{"id":"https://openalex.org/W56541714","doi":"https://doi.org/10.1254/fpj.123.349","title":"Pharmacological and pharmacokinetic features and clinical effects of pitavastatin (Livalo Tablet\u00ae)","display_name":"Pharmacological and pharmacokinetic features and clinical effects of pitavastatin (Livalo Tablet\u00ae)","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W56541714","doi":"https://doi.org/10.1254/fpj.123.349","mag":"56541714","pmid":"https://pubmed.ncbi.nlm.nih.gov/15118259"},"language":"ja","primary_location":{"id":"doi:10.1254/fpj.123.349","doi":"https://doi.org/10.1254/fpj.123.349","is_oa":true,"landing_page_url":"https://doi.org/10.1254/fpj.123.349","pdf_url":"https://www.jstage.jst.go.jp/article/fpj/123/5/123_5_349/_pdf","source":{"id":"https://openalex.org/S156890813","display_name":"Folia Pharmacologica Japonica","issn_l":"0015-5691","issn":["0015-5691","0369-4461","1347-8397","2185-307X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Folia Pharmacologica Japonica","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/fpj/123/5/123_5_349/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019349961","display_name":"Hiroyuki Yamazaki","orcid":"https://orcid.org/0000-0002-5633-8997","observed_orcids":["https://orcid.org/0000-0002-5633-8997"]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroyuki YAMAZAKI","raw_affiliation_strings":["Atherosclerosis Research Dept., Tokyo New Drug Research Laboratories I, Kowa Company, Ltd., Higashimurayama, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atherosclerosis Research Dept., Tokyo New Drug Research Laboratories I, Kowa Company, Ltd., Higashimurayama, Tokyo, Japan","institution_ids":["https://openalex.org/I4210088742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051318143","display_name":"Hideki Fujino","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hideki FUJINO","raw_affiliation_strings":["\u8208\u548c(\u682a) \u6771\u4eac\u5275\u85ac\u7b2c\u4e00\u7814\u7a76\u6240 \u52d5\u8108\u786c\u5316\u7814\u7a76\u90e8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u8208\u548c(\u682a) \u6771\u4eac\u5275\u85ac\u7b2c\u4e00\u7814\u7a76\u6240 \u52d5\u8108\u786c\u5316\u7814\u7a76\u90e8","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078205108","display_name":"Mizuho Kanazawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mizuho KANAZAWA","raw_affiliation_strings":["\u8208\u548c(\u682a) \u5b66\u8853\u7b2c\u4e00\u90e8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u8208\u548c(\u682a) \u5b66\u8853\u7b2c\u4e00\u90e8","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112566013","display_name":"Taro Tamaki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Taro TAMAKI","raw_affiliation_strings":["\u8208\u548c(\u682a) \u6771\u4eac\u5275\u85ac\u7b2c\u4e00\u7814\u7a76\u6240 \u52d5\u8108\u786c\u5316\u7814\u7a76\u90e8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u8208\u548c(\u682a) \u6771\u4eac\u5275\u85ac\u7b2c\u4e00\u7814\u7a76\u6240 \u52d5\u8108\u786c\u5316\u7814\u7a76\u90e8","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110007515","display_name":"Fumiyasu Sato","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fumiyasu SATO","raw_affiliation_strings":["\u8208\u548c(\u682a) \u6771\u4eac\u5275\u85ac\u7b2c\u4e00\u7814\u7a76\u6240 \u52d5\u8108\u786c\u5316\u7814\u7a76\u90e8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u8208\u548c(\u682a) \u6771\u4eac\u5275\u85ac\u7b2c\u4e00\u7814\u7a76\u6240 \u52d5\u8108\u786c\u5316\u7814\u7a76\u90e8","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102127321","display_name":"Mikio Suzuki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112703","display_name":"Nissan Chemical Corporation (Japan)","ror":"https://ror.org/01skwyh03","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112703"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mikio SUZUKI","raw_affiliation_strings":["\u65e5\u7523\u5316\u5b66\u5de5\u696d(\u682a) \u7269\u8cea\u79d1\u5b66\u7814\u7a76\u6240 \u533b\u85ac\u7814\u7a76\u90e8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u65e5\u7523\u5316\u5b66\u5de5\u696d(\u682a) \u7269\u8cea\u79d1\u5b66\u7814\u7a76\u6240 \u533b\u85ac\u7814\u7a76\u90e8","institution_ids":["https://openalex.org/I4210112703"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108585738","display_name":"Masaki Kitahara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112703","display_name":"Nissan Chemical Corporation (Japan)","ror":"https://ror.org/01skwyh03","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112703"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaki KITAHARA","raw_affiliation_strings":["\u65e5\u7523\u5316\u5b66\u5de5\u696d(\u682a) \u751f\u7269\u79d1\u5b66\u7814\u7a76\u6240 \u533b\u85ac\u7814\u7a76\u90e8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u65e5\u7523\u5316\u5b66\u5de5\u696d(\u682a) \u751f\u7269\u79d1\u5b66\u7814\u7a76\u6240 \u533b\u85ac\u7814\u7a76\u90e8","institution_ids":["https://openalex.org/I4210112703"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2802,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.31971921,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"123","issue":"5","first_page":"349","last_page":"362"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pitavastatin","display_name":"pitavastatin","score":1.0},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9340000152587891},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7910000085830688},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.7390000224113464},{"id":"https://openalex.org/keywords/cyp2c9","display_name":"CYP2C9","score":0.949999988079071},{"id":"https://openalex.org/keywords/hepatic-ldl-receptor","display_name":"hepatic LDL receptor","score":0.8859999775886536},{"id":"https://openalex.org/keywords/vldl-secretion","display_name":"VLDL secretion","score":0.9890000224113464},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.902999997138977},{"id":"https://openalex.org/keywords/triglyceride-lowering","display_name":"triglyceride lowering","score":0.949999988079071},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.5400000214576721},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5099999904632568}],"concepts":[{"id":"https://openalex.org/C2776692505","wikidata":"https://www.wikidata.org/wiki/Q412677","display_name":"Pitavastatin","level":3,"score":0.9138610363006592},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.633478045463562},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6226480007171631},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5639767646789551},{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001161","descriptor_name":"Arteriosclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001161","descriptor_name":"Arteriosclerosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011345","descriptor_name":"Fenofibrate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011973","descriptor_name":"Receptors, LDL","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015243","descriptor_name":"Cholesterol, VLDL","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018565","descriptor_name":"Food-Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D032083","descriptor_name":"Citrus paradisi","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1254/fpj.123.349","doi":"https://doi.org/10.1254/fpj.123.349","is_oa":true,"landing_page_url":"https://doi.org/10.1254/fpj.123.349","pdf_url":"https://www.jstage.jst.go.jp/article/fpj/123/5/123_5_349/_pdf","source":{"id":"https://openalex.org/S156890813","display_name":"Folia Pharmacologica Japonica","issn_l":"0015-5691","issn":["0015-5691","0369-4461","1347-8397","2185-307X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Folia Pharmacologica Japonica","raw_type":"journal-article"},{"id":"pmid:15118259","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15118259","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nihon yakurigaku zasshi. Folia pharmacologica Japonica","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1254/fpj.123.349","doi":"https://doi.org/10.1254/fpj.123.349","is_oa":true,"landing_page_url":"https://doi.org/10.1254/fpj.123.349","pdf_url":"https://www.jstage.jst.go.jp/article/fpj/123/5/123_5_349/_pdf","source":{"id":"https://openalex.org/S156890813","display_name":"Folia Pharmacologica Japonica","issn_l":"0015-5691","issn":["0015-5691","0369-4461","1347-8397","2185-307X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313602","host_organization_name":"Japanese Pharmacological Society","host_organization_lineage":["https://openalex.org/P4310313602"],"host_organization_lineage_names":["Japanese Pharmacological Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Folia Pharmacologica Japonica","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W56541714.pdf","grobid_xml":"https://content.openalex.org/works/W56541714.grobid-xml"},"referenced_works_count":44,"referenced_works":["https://openalex.org/W158929996","https://openalex.org/W1881846348","https://openalex.org/W1970761589","https://openalex.org/W1971242943","https://openalex.org/W1975151125","https://openalex.org/W1985258130","https://openalex.org/W1990114889","https://openalex.org/W1993395893","https://openalex.org/W1998336053","https://openalex.org/W2003382978","https://openalex.org/W2004175671","https://openalex.org/W2005840421","https://openalex.org/W2007746673","https://openalex.org/W2008933139","https://openalex.org/W2010474851","https://openalex.org/W2016505247","https://openalex.org/W2019352040","https://openalex.org/W2021888728","https://openalex.org/W2022698380","https://openalex.org/W2031641590","https://openalex.org/W2032622924","https://openalex.org/W2036015501","https://openalex.org/W2051707451","https://openalex.org/W2055274038","https://openalex.org/W2056530140","https://openalex.org/W2073364445","https://openalex.org/W2082252581","https://openalex.org/W2084744450","https://openalex.org/W2092467013","https://openalex.org/W2099891679","https://openalex.org/W2106642167","https://openalex.org/W2109063792","https://openalex.org/W2146544786","https://openalex.org/W2155598961","https://openalex.org/W2157245535","https://openalex.org/W2159042889","https://openalex.org/W2169050770","https://openalex.org/W2192767584","https://openalex.org/W2271485412","https://openalex.org/W2321738746","https://openalex.org/W2608539973","https://openalex.org/W2949155240","https://openalex.org/W4245139922","https://openalex.org/W4246764494"],"related_works":["https://openalex.org/W2335695911","https://openalex.org/W1534063655","https://openalex.org/W2022795891","https://openalex.org/W1581672536","https://openalex.org/W4254069279","https://openalex.org/W2161148887","https://openalex.org/W2062869423","https://openalex.org/W2177843780","https://openalex.org/W2074541010","https://openalex.org/W2166091190"],"abstract_inverted_index":{"Today":[0],"3-hydroxy-3-methylglutaryl-coenzyme":[1],"A":[2],"(HMG-CoA)":[3],"reductase":[4],"inhibitors":[5],"(statins)":[6],"are":[7],"the":[8,14,31,56,68,134,169,204,226,259],"most":[9],"often":[10],"prescribed":[11],"drugs":[12,200],"among":[13],"therapeutics":[15],"for":[16,238],"hypercholesterolemia.":[17,262],"Pitavastatin":[18,240],"is":[19,52,119,146,178,193,251],"a":[20,72,90,255],"novel":[21],"statin":[22,40],"that":[23,50,176],"has":[24],"been":[25],"developed":[26],"entirely":[27],"in":[28,89,166,225],"Japan":[29],"from":[30],"biological":[32],"screening":[33],"to":[34,55,67,70,121,150,164,168,195,253,258],"clinical":[35,206],"studies":[36,45],"persuing":[37],"more":[38],"efficatious":[39],"than":[41],"hitherto":[42],"known.":[43],"Preclinical":[44],"on":[46],"drug":[47,248],"metabolism":[48],"revealed":[49],"pitavastatin":[51,79,118,177,192,211],"distributed":[53],"selectively":[54],"liver,":[57],"excreted":[58],"into":[59],"bile":[60],"without":[61],"metabolic":[62],"modification,":[63],"and":[64,85,94,105,113,131,137,214,218,231,250],"efficiently":[65],"re-circulates":[66],"liver":[69,91],"show":[71],"prolonged":[73],"plasma":[74,97,243],"half-life.":[75],"In":[76,203],"guinea":[77],"pigs,":[78],"enhanced":[80],"hepatic":[81],"LDL":[82,123,128],"receptor":[83,129],"activity":[84],"reduced":[86],"VLDL":[87,143],"secretion":[88],"perfusion":[92],"study,":[93],"it":[95],"lowered":[96,212],"total":[98],"cholesterol":[99,124],"(TC)":[100],"levels":[101,108],"at":[102,109],"0.3":[103],"mg/kg":[104],"triglyceride":[106],"(TG)":[107],"1":[110],"mg/kg,":[111],"respectively,":[112],"more.":[114],"From":[115],"these":[116],"results,":[117],"assumed":[120],"lower":[122],"(LDL-C)":[125],"by":[126,141,189,216],"promoting":[127],"expression":[130],"further":[132],"potentiate":[133],"cholesterol-lowering":[135],"effect":[136,140,235],"exert":[138],"TG-lowering":[139],"reducing":[142],"secretion.":[144],"(14)C-Pitavastatin":[145],"metabolized":[147],"with":[148,199,208],"CYP2C9":[149],"8-hydroxy":[151],"derivative,":[152],"but":[153],"its":[154],"Vmax":[155],"/Km":[156],"was":[157,222,236],"about":[158,162],"2":[159],"micro":[160],"l/min/mg,":[161],"1/8":[163],"1/100":[165],"comparison":[167],"reported":[170],"values":[171],"of":[172,228,261],"other":[173,182],"statins,":[174],"indicating":[175],"hardly":[179],"metabolized.":[180],"Also,":[181],"human":[183],"P450":[184],"species":[185],"were":[186],"not":[187],"inhibited":[188],"pitavastatin.":[190,239],"Therefore,":[191],"considered":[194],"have":[196],"little":[197,247],"interaction":[198],"through":[201],"P450.":[202],"summarized":[205],"results":[207],"862":[209],"patients,":[210],"TC":[213],"LDL-C":[215],"28%":[217],"40%,":[219],"respectively.":[220],"There":[221],"no":[223,232],"difference":[224],"frequency":[227],"side":[229],"effects":[230],"serious":[233],"adverse":[234],"observed":[237],"possesses":[241],"superior":[242],"lipid-improving":[244],"effects,":[245],"induces":[246],"interaction,":[249],"expected":[252],"make":[254],"good":[256],"contribution":[257],"medication":[260]},"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}